Beta Bionics Inc.
BBNX | NASDAQ
$16.55
-$0.20 (-1.19%)
Nov 2, 2026, 10:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Net Income | -73.2M | -54.76M | -44.1M | -64.75M |
Depreciation & Amortization | 2.88M | 2.28M | 2.09M | 2.09M |
Stock-Based Compensation | 16.38M | 6.38M | 5.66M | 6.1M |
Other Working Capital | 3.95M | 5.39M | -340K | -2.71M |
Other Non-Cash Items | 12.01M | 9.96M | 9.21M | -854K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.99M | -12.15M | -5.31M | -2.79M |
Operating Cash Flow | -50.93M | -48.27M | -32.45M | -60.21M |
Capital Expenditures | -5.3M | -3.4M | -402K | -772K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -327.51M | -72.13M | -69.3M | n/a |
Sales Maturities Of Investments | 170M | 72M | n/a | n/a |
Other Investing Acitivies | n/a | 50K | 4K | 3K |
Investing Cash Flow | -162.81M | -3.48M | -69.69M | -769K |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.15M | n/a | n/a |
Financial Cash Flow | 214.87M | 55.62M | 101.03M | 56.78M |
Net Cash Flow | 1.14M | 3.87M | -1.11M | -4.2M |
Free Cash Flow | -56.22M | -51.67M | -32.85M | -60.98M |
Adj. Free Cash Flow | -72.61M | -58.05M | -38.51M | -67.08M |
Maintenance CapEx | n/a | n/a | n/a | -772K |
Growth CapEx | -5.3M | -3.4M | -402K | n/a |
Owner Earnings | -50.93M | -48.27M | -32.45M | -60.98M |
Add to Watchlist
Select watchlists to add or remove BBNX